Menu
Your Cart

Search

With the help of Apostle MiniMax cfDNA Isolation Technology, a recent clinical study demonstrated the clinical validity of the circulating cell-free DNA for hepatocellular carcinoma (HCC) detection with high sensitivity and specificity, published in Science Translational Medicine.